Houston-based cell therapy company FibroBiologics files to go public
Houston-based cell therapy company FibroBiologics has filed for a direct listing on the Nasdaq Global Market after previously putting off going public.
Building "Bridges" Across the Bayou City!
Houston-based cell therapy company FibroBiologics has filed for a direct listing on the Nasdaq Global Market after previously putting off going public.